Life-Cycle Assessment and Product Carbon Footprint for Pharma

Life-Cycle Assessment and Product Carbon Footprint for Pharma
Product Description

Positive Organizations conducts product and process life-cycle assessments to ISO 14040 and ISO 14044, quantifying the environmental impact of an API, a formulation, a device or a packaging system from raw material to end of life.


In pharmaceutical manufacturing the impact is concentrated upstream in solvent use, synthesis route, energy intensity and packaging, and an LCA is what shows where. It is also the evidence base for the product-level claims that regulators now expect to be substantiated by measured value-chain data.


We deliver the full study with reporting, and support third-party certification such as an Environmental Product Declaration or ISO 14067 product carbon footprint.


An LCA Tool variant gives you an interactive model to reassess formulations, suppliers and packaging changes yourself over time.

Read more Show less

Positive Organizations

  • Country/Region:
    Switzerland
  • On CPHI since:
    2026
  • Certificates:
    1
  • Employees:
    1 - 24
Company types
Consultancy
Primary activities
Other
Regulatory Affairs
View company profile
Categories
more categories Show less
Specifications
  • Details
    Standards: ISO 14040 and ISO 14044 principles and requirements, ISO 14067 product carbon footprint, ISO 14025 and EN 15804 for Environmental Product Declarations, GHG Protocol Product Standard.


    Scope: goal and scope definition, functional unit and system boundary; life-cycle inventory including solvents, reagents, utilities, primary and secondary packaging and distribution; impact assessment across climate change, water, acidification, eutrophication and resource use; interpretation, sensitivity and hotspot analysis; critical review and third-party certification support; LCA Tool variant with an interactive reassessment model for ongoing monitoring and scenario testing.


    Application areas: APIs and intermediates, finished dose forms, excipients, primary and secondary packaging, medical devices, laboratory consumables, contract manufacturing processes.
  • Selling Points
    Green Product; International Approvals/Standards; Quality Service; - Cradle-to-gate and cradle-to-grave studies built for external review
    - Solvent, synthesis route and packaging hotspots quantified, not estimated
    - Feeds Scope 3 category 1 with primary data your customers will accept
    - Supports EPD and ISO 14067 certification
    - Interactive tool variant so you can retest changes without a new study
    - Substantiates product claims under EU green claims rules
  • Supplied from
    Switzerland
More specifications Fewer specifications
Sales Markets
Show more Show less

Positive Organizations

  • Country/Region:
    Switzerland
  • On CPHI since:
    2026
  • Certificates:
    1
  • Employees:
    1 - 24
Company types
Consultancy
Primary activities
Other
Regulatory Affairs
View company profile

More Products from Positive Organizations (10)

  • Corporate Carbon Footprint, Decarbonization and Energy Assessment

    Product Corporate Carbon Footprint, Decarbonization and Energy Assessment

    Positive Organizations calculates your corporate carbon footprint, a greenhouse gas inventory covering Scope 1, Scope 2 and material Scope 3 categories, and then turns it into a reduction plan.


    At least 55 percent of pharmaceutical emissions sit in Scope 3, and manufacturing accounts for the maj...
  • EcoVadis, CDP and S&P CSA Rating Support and Gap Analysis

    Product EcoVadis, CDP and S&P CSA Rating Support and Gap Analysis

    Positive Organizations is an EcoVadis Accredited Consulting Partner and Approved Training Partner, and improves the ratings your pharmaceutical customers use to screen suppliers.


    EcoVadis scores you from 0 to 100 across Environment, Labor and Human Rights, Ethics and Sustainable Procurement, jud...
  • ESG Governance, Policies, Training, DEI and Leadership Coaching

    Product ESG Governance, Policies, Training, DEI and Leadership Coaching

    Positive Organizations puts the governance layer in place that ESG ratings, auditors and customers all look for, and then makes it live in the organisation.


    We draft the ESG documentation suite: whistleblower policy and reporting channel, code of conduct, code of ethics, human rights, anti-corru...
  • ESG Strategy, Materiality and Risk Assessment for Pharma

    Product ESG Strategy, Materiality and Risk Assessment for Pharma

    Positive Organizations builds the ESG strategy that sits underneath everything else, so your reporting, ratings and customer questionnaires draw on one coherent plan instead of ad hoc answers.


    We begin with an ESG maturity assessment and a peer benchmark against comparable pharmaceutical manufac...
  • ESG Supply Chain Due Diligence and Supplier Assessment

    Product ESG Supply Chain Due Diligence and Supplier Assessment

    Positive Organizations builds the supplier ESG due diligence system that pharmaceutical procurement now requires, and that upstream regulation increasingly assumes.


    Around 55 percent or more of pharmaceutical emissions and most human rights exposure sit with suppliers, and 69 percent of pharma l...
  • ISO Certifications and B Corp Certification Support

    Product ISO Certifications and B Corp Certification Support

    Positive Organizations takes pharmaceutical companies and suppliers through management system certification and B Corp certification, from gap analysis to certificate.


    We support ISO 14001 environmental management, ISO 50001 energy management, ISO 45001 occupational health and safety, ISO 20121 ...
  • PPWR Readiness Assessment for Pharma Packaging

    Product PPWR Readiness Assessment for Pharma Packaging

    Regulation (EU) 2025/40 (PPWR) has applied across the EU-27 since 12 August 2026. For pharma the exposure is uneven: primary packaging of medicinal products is exempt from the recyclability and recycled-content targets — but that exemption has to be documented, and secondary, transport and e-commerce packa...
  • Sustainability Reporting: GRI, CSRD and ESRS, plus ESG Data Management

    Product Sustainability Reporting: GRI, CSRD and ESRS, plus ESG Data Management

    Positive Organizations produces GRI-aligned and CSRD-compliant sustainability reports for pharmaceutical companies and their suppliers.


    Following the Omnibus I Directive (EU) 2026/470, mandatory ESRS reporting now applies to undertakings with more than 1,000 employees and over EUR 450 million tu...
  • Carbon Neutrality to ISO 14068-1 and Credible Climate Claims

    Product Carbon Neutrality to ISO 14068-1 and Credible Climate Claims

    Positive Organizations supports pharmaceutical companies that want to make a carbon neutrality claim and have it stand up to scrutiny.


    The rules changed. From 27 September 2026, Directive (EU) 2024/825 on empowering consumers for the green transition prohibits product claims such as carbon neutr...
  • Circular Economy, Resource Efficiency and Reffnet Consultancy

    Product Circular Economy, Resource Efficiency and Reffnet Consultancy

    Positive Organizations helps pharmaceutical manufacturers and packaging suppliers cut material and resource losses and build a credible circularity position.


    We map resource and material flows across your processes, visualise them with Sankey diagrams, benchmark efficiency against comparable ope...